The role of human CD46 in early xenoislet engraftment in a dual transplant model.

Published online

Journal Article

BACKGROUND: Membrane cofactor protein CD46 attenuates the complement cascade by facilitating cleavage of C3b and C4b. In solid organ xenotransplantation, organs expressing CD46 have been shown to resist hyperacute rejection. However, the incremental value of human CD46 expression for islet xenotransplantation remains poorly defined. METHODS: This study attempted to delineate the role of CD46 in early neonatal porcine islet engraftment by comparing Gal-knocked out (GKO) and hCD46-transgenic (GKO/CD46) islets in a dual transplant model. Seven rhesus macaques underwent dual transplant and were sacrificed at 1 hour (n = 4) or 24 hours (n = 3). Both hemilivers were recovered and fixed for immunohistochemistry (CD46, insulin, neutrophil elastase, platelet, IgM, IgG, C3d, C4d, CD68, Caspase 3). Quantitative immunohistochemical analysis was performed using the Aperio Imagescope. RESULTS: Within 1 hour of intraportal infusion of xenografts, no differences were observed between the two types of islets in terms of platelet, antibody, or complement deposition. Cellular infiltration and islet apoptotic activity were also similar at 1 hour. At 24 hours, GKO/CD46 islets demonstrated significantly less platelet deposition (P = 0.01) and neutrophil infiltration (P = 0.01) compared to GKO islets. In contrast, C3d (P = 0.38) and C4d (P = 0.45) deposition was equal between the two genotypes. CONCLUSIONS: Our findings suggest that expression of hCD46 on NPIs potentially provides a measurable incremental survival advantage in vivo by reducing early thrombo-inflammatory events associated with instant blood-mediated inflammatory reaction (IBMIR) following intraportal islet infusion.

Full Text

Duke Authors

Cited Authors

  • Samy, KP; Gao, Q; Davis, RP; Song, M; Fitch, ZW; Mulvihill, MS; MacDonald, AL; Leopardi, FV; How, T; Williams, KD; Devi, GR; Collins, BH; Luo, X; Kirk, AD

Published Date

  • June 20, 2019

Published In

Start / End Page

  • e12540 -

PubMed ID

  • 31219218

Pubmed Central ID

  • 31219218

Electronic International Standard Serial Number (EISSN)

  • 1399-3089

Digital Object Identifier (DOI)

  • 10.1111/xen.12540

Language

  • eng

Conference Location

  • Denmark